Lobbying Filing Details

Total Spending

$250,000

Activities

1

Lobbyists

2

Gov't Entities

2

Filing Information
Filing UUID:
9cb53788-6ede-44f7-8778-afe1ae6a7f72
Type:
2A - 2nd Quarter - Amendment
Period:
2024 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
August 15, 2024 at 2:51 PM
Income:
$0
Expenses:
$250,000
Expense Method:
A
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Amanda Pezalla
Registrant
DAIICHI SANKYO, INC.
Basking Ridge, New Jersey
Client
DAIICHI SANKYO INC
District of Columbia, United States of America
Lobbying Activities (1)
Activity 1
Health Issues

Discussions regarding H.R.5539, the ORPHAN Cures Act Discussions related to H.R.4534 - the Women and Lung Cancer Research and Preventive Services Act Discussions related to H.R.5391 - the Protecting Patient Access to Cancer and Complex Therapies Act 340B reform generally as well as HR8574 - the 340B ACCESS Act

Foreign Entity Issues: To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.

Lobbyists (2)
  • AMANDA PEZALLA
  • AARON BILL
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 12, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.